Source: International Congress 2016 – Challenges in the management of non-CF bronchiectasis



Rating:

Share or cite this content

Citations should be made in the following way:
Felix Ringshausen (Hannover Medical School, Hannover, Germany), Anthony De Soyza (Newcastle University and Freeman Hospital, Newcastle upon Tyne, UK), Timothy Aksamit (Mayo Clinic, Rochester, MN, USA). Challenges in the management of non-CF bronchiectasis. International Congress 2016 – Challenges in the management of non-CF bronchiectasis

Member's Comments

No comment yet.

Related content which might interest you: Prognostic indicators of adult patients with non-CF bronchiectasis and those with combined COPD and non-CF bronchiectasis Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Inpatient management of non-CF bronchiectasis: Should patients be managed as in CF? Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Knowledge and adherence of airway clearance techniques in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Respiratory physiotherapy: outcomes in disease and health Year: 2015 Diagnosis and management of non-cystic fibrosis bronchiectasis in children Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment Year: 2018 Management and prevention of non-cystic fibrosis bronchiectasis Source: International Congress 2015 – PG9 Lower respiratory tract infection in children Year: 2015 NTM in cystic fibrosis and non-CF bronchiectasis Source: ERS Course 2015 Year: 2015 The management of non-CF bronchiectasis in Europe: data from the European Bronchiectasis Network Source: International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC) Year: 2015 Sputum analysis and management of non-CF bronchiectasis in Singleton hospital Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Late Breaking Abstract - Benefits of a low-frequency airway clearance technology in non-CF patients with bronchiectasis Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction Year: 2018 Interactive case study ‘Controversies in managing P. aeruginosa in non-CF bronchiectasis’ Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video Year: 2014 Predicting hospital admissions in non-CF bronchiectasis using COPD specific severity tools Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 The effect of exacerbations on the airway microbiota in children with non-CF bronchiectasis Source: International Congress 2019 – A mixture of rare lung diseases Year: 2019 Aetiology of non-CF bronchiectasis in adults and its association to quality of life Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 The low dose macrolides for prevention of exacerbations in non-CF bronchiectasis Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 Management of bronchiectasis Source: Breathe 2010; 6: 353-360 Year: 2010 Non-invasive evaluation of airway inflammation in non-CF bronchiectasis Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016